This book comprehensively covers a broad range of therapeutic and diagnostic applications of nanotechnology, providing descriptions of cutting-edge discoveries along with historical perspectives. The text focuses on nanomaterials and nanoparticles, the sectors that hold the most promise for the future of medicine. The author look at how nanotechnology can impact cancer treatment, clinical neuroscience, tissue engineering, drug delivery, and diagnostics. He also discusses the worldwide governmental regulatory impact on nanomedicine.
- Addresses the latest findings and intriguing possibilities in nanomedicine, drawing on real data and published research from the medical sciences
- Covers the historical evolution of nanotechnology
- Looks at how nanotechnology can impact major areas of medicine, including cancer treatment, clinical neuroscience, tissue engineering, drug delivery, and diagnostics
- Discusses the worldwide governmental regulatory impact on nanomedicine
Table of Contents
- Fundamentals of Nanotechnology
- Nanoparticles and Hyperthermic Cancer Therapeutics
- Nanofiber-Based Scaffolds and Tissue Engineering
- Nanotechnology and Neuroscience
- Nanotechnology and Surgery
- Nanomatrices for Cell Culture
- Nanoparticle-Based Drug Delivery
- Government Influence on Nanotechnology
- Future Concepts in Nanomedicine
Rob Burgess is a scientist, entrepreneur, businessman, and author who switched scientific disciplines in 2006 at the age of 38 to take a chance on nanotechnology. It changed his life forever. He has held numerous academic and industry-related positions, including research fellow at the University of California, San Diego; founding scientist at Lexicon Genetics Incorporated; founder and president at Genome Biosciences Incorporated; vice president, research and development, at Zyvex Corporation; and vice president, business development, at Stem Cell Sciences, LLC. He is currently founder, chairman, and president at Medical Nanotechnologies Incorporated and an adjunct professor in the Department of Molecular and Cell Biology at the University of Texas, Dallas. He holds a bachelor of arts in biochemistry from the University of Texas, Austin, and a Ph.D. in molecular biology from the University of Texas M.D. Anderson Cancer Center, Houston..